CMS Open Payments · Program Year 2024
Boehringer Ingelheim Espana S.A.
Boehringer Ingelheim Espana S.A. reported $382,770.85 across General Payments, Research, and Ownership to 2 physicians and teaching hospitals across 32 transactions.
- $382.8K Above-median payer
- All-tracks total
- 32 Below-median volume
- Transactions
- 2 Below-median reach
- Recipients
- #837
- of 1,925 companies
Boehringer Ingelheim Espana S.A. reported $382,770.85 across all CMS Open Payments tracks (General + Research + Ownership) to 2 physicians and teaching hospitals in Program Year 2024 - ranking #837 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,575.36, averaging $191.4K per recipient.
How Boehringer Ingelheim Espana S.A.'s $382.8K all-tracks total breaks down
Boehringer Ingelheim Espana S.A.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
11/100
Total payments
F
14/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer boehringer-ingelheim-espana-s-a Boehringer Ingelheim Espana S.A.
$382.8K · #837/1,925 · 0.0% industry · PY2024
- TOT $382.8K
- RANK #837
- SHARE 0.0%
- TXN 32
- RCP 2
- CAT 1
- GEN $1.6K
- TOP1 61.5%
- PY 2024
Volume peers
Nearest volume peer: Vifor Pharma, Inc. ($383.6K)
Boehringer Ingelheim Espana S.A. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Boehringer Ingelheim Espana S.A.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Boehringer Ingelheim Espana S.A., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $1.6K, accounting for 100.0% of this company's General Payments and 2 transactions.
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Boehringer Ingelheim Espana S.A.'s 1-category general-payment breakdown at $1.6K, 100.0% of the reported total.
How Boehringer Ingelheim Espana S.A. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $1.6K | 2 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,575.36 (100.0%) of $1,575.36 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Boehringer Ingelheim Espana S.A.
The five named recipients with the highest reported General Payments from this company
- 1
Stephen Marder
$969.45 across 1 reported transactions
- 2
Christoph U Correll
$605.91 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Boehringer Ingelheim Espana S.A. ranks #837 of 1,925 by total payments (top 43% by spend) but is notably more concentrated than that alone would suggest -- #319 of 1,838 by HHI (top 17% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Affordable Pharmaceuticals, LLC : $766.7K total payments, HHI 5325
- AstraZeneca UK Limited : $15.4M total payments, HHI 5304
- Shimadzu Precision Instruments, Inc. : $67.9K total payments, HHI 5279
- AppliedVR Inc : $189.1K total payments, HHI 5275
- Partner Therapeutics, Inc. : $378.4K total payments, HHI 5272
- Gyrus ACMI, Inc. : $304.0K total payments, HHI 5269
- Boehringer Ingelheim Espana S.A. (this company) : $1.6K total payments, HHI 5266
- BioPoly LLC : $35.8K total payments, HHI 5258
- Vascular Graft Solutions Inc : $230.03 total payments, HHI 5258
- Nipro Medical Corporation : $8.2K total payments, HHI 5256
- Celgene Corporation : $10.7M total payments, HHI 5254
- Suture Ease, Inc. : $12.9K total payments, HHI 5248
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Boehringer Ingelheim Espana S.A.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Boehringer Ingelheim Espana S.A..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Boehringer Ingelheim Espana S.A..
Showing 6 of 1,924 companies with CMS-reported payment data.
Flower Orthopedics Coporation
CraniUS LLC
Elekta Instrument AB
Daxor Corporation
Beaver-Visitec International, Inc.
Put this to use
Boehringer Ingelheim Espana S.A. ranks #837 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Boehringer Ingelheim Espana S.A.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.